Biotech companies report on drugs to treat head and neck, lung cancers

06/7/2004 | Reuters · Wall Street Journal, The

Genentech and ImClone reported success in developing a pair of drugs that treat head and neck cancer and lung cancer, respectively. Genentech said combining its Tarceva and Avastin can extend the survival rate of patients with lung cancer and ImClone said Erbitux, FDA-approved for treating colon cancer, can work with radiation to increase the median survival rate of patients with head and neck cancer.

View Full Article in:

Reuters · Wall Street Journal, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Research
America's Heatlh Insurance Plans (AHIP)
Washington, DC
Deputy Director, Marketing
America's Heatlh Insurance Plans (AHIP)
Washington, DC
Director of Operations - GBS
Mayo Clinic
MN
Director of Actuarial Services, Government Programs
PacificSource
OR
Regional Director, Southeastern Region - State Affairs
America's Health Insurance Plans (AHIP)
Washington, DC